|
|
|
Insider
Information: |
Rosenwald Lindsay A Md |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
13 |
|
Direct
Shares |
37,631,451 |
|
Indirect Shares
|
13,489,834 |
|
|
Direct
Value |
$67,681,835 |
|
|
Indirect Value
|
$48,000,247 |
|
|
Total
Shares |
51,121,285 |
|
|
Total
Value |
$115,682,082 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
8
|
0
|
Stock
price went up :
|
2
|
0
|
Stock
price went down : |
6
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-25.3%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Genta Inc De |
GNTAQ |
10% Owner |
2003-07-14 |
21,531,885 |
2004-02-13 |
656,191 |
Premium* |
|
Soligenix Inc Common |
SNGX |
10% Owner |
2004-02-12 |
0 |
2004-02-12 |
3,230,922 |
Premium* |
|
TG Therapeutics Inc |
TGTX |
10% Owner |
2005-05-11 |
2,649,321 |
2005-05-11 |
2,682,507 |
Premium* |
|
Cypress Bioscience Inc |
CYPB |
10% Owner |
2004-01-09 |
0 |
2004-01-13 |
2,210,848 |
Premium* |
|
Keryx Biopharmaceuticals Inc |
KERX |
Director |
2006-05-22 |
1,735,863 |
2006-05-22 |
320,786 |
Premium* |
|
Alaunos Therapeutics |
TCRT |
10% Owner |
2005-09-13 |
476,678 |
2005-09-13 |
737,777 |
Premium* |
|
Chem Rx Corporation |
CHRXU |
Officer, Director, 10%... |
2005-10-21 |
584,375 |
2005-10-21 |
584,375 |
Premium* |
|
Velcera Inc |
VLCR |
10% Owner |
2006-01-17 |
121,205 |
|
0 |
Premium* |
|
Fortress Biotech, Inc. |
FBIO |
President, CEO & Chair... |
2024-01-05 |
2,863,905 |
2017-01-01 |
2,367,666 |
Premium* |
|
National Holdings Corp |
NHLD |
10% Owner |
2016-09-12 |
7,037,482 |
2016-09-12 |
522,292 |
Premium* |
|
Checkpoint Therapeutics, Inc. |
CKPT |
Director |
2024-05-14 |
132,174 |
2017-07-10 |
0 |
Premium* |
|
Avenue Therapeutics, Inc. |
ATXI |
Director |
2023-09-08 |
354,318 |
|
0 |
Premium* |
|
Journey Medical Ord Shs |
DERM |
Director |
2024-03-25 |
144,245 |
2024-03-25 |
176,470 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
164 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TCRT |
Alaunos Therapeutics |
10% Owner |
|
2005-09-13 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
737,777 |
|
- |
|
TCRT |
Alaunos Therapeutics |
10% Owner |
|
2005-09-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
476,678 |
|
- |
|
CHRXU |
Chem Rx Corporation |
Chairman of the BoardOfficer |
|
2005-10-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
584,375 |
|
- |
|
CHRXU |
Chem Rx Corporation |
Chairman of the BoardOfficer |
|
2005-10-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
584,375 |
|
- |
|
VLCR |
Velcera Inc |
officerTitle |
|
2006-01-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
121,205 |
|
- |
|
FBIO |
Fortress Biotech, Inc. |
Director |
|
2011-09-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,047,632 |
|
- |
|
FBIO |
Fortress Biotech, Inc. |
Director |
|
2011-09-13 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,154,619 |
|
- |
|
NHLD |
National Holdings Corp |
10% Owner |
|
2016-09-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,037,482 |
|
- |
|
NHLD |
National Holdings Corp |
10% Owner |
|
2016-09-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
522,292 |
|
- |
|
ATXI |
Avenue Therapeutics, Inc. |
Director |
|
2017-03-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,000 |
|
- |
|
DERM |
Journey Medical Ord Shs |
Director |
|
2021-11-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
176,470 |
|
- |
|
TGTX |
TG Therapeutics Inc |
10% Owner |
|
2005-03-22 |
4 |
B |
$1.53 |
$765 |
D/D |
500 |
2,542,621 |
2.37 |
- |
|
FBIO |
Fortress Biotech, Inc. |
President and CEO |
|
2015-12-01 |
4 |
B |
$2.41 |
$1,412 |
D/D |
586 |
4,792,692 |
3.15 |
- |
|
FBIO |
Fortress Biotech, Inc. |
President and CEO |
|
2016-06-01 |
4 |
B |
$2.40 |
$1,471 |
D/D |
613 |
5,303,739 |
3.15 |
- |
|
FBIO |
Fortress Biotech, Inc. |
President and CEO |
|
2016-12-01 |
4 |
B |
$2.03 |
$1,484 |
D/D |
731 |
5,304,470 |
3.15 |
- |
|
FBIO |
Fortress Biotech, Inc. |
President and CEO |
|
2015-06-01 |
4 |
B |
$1.80 |
$1,413 |
D/D |
785 |
4,792,106 |
3.15 |
- |
|
FBIO |
Fortress Biotech, Inc. |
President and CEO |
|
2014-12-01 |
4 |
B |
$1.45 |
$1,412 |
D/D |
974 |
4,791,321 |
3.15 |
- |
|
TGTX |
TG Therapeutics Inc |
10% Owner |
|
2004-09-09 |
4 |
B |
$0.95 |
$950 |
D/D |
1,000 |
2,240,521 |
2.37 |
- |
|
FBIO |
Fortress Biotech, Inc. |
PRESIDENT, CEO & CHAIRMAN |
|
2019-12-01 |
4 |
B |
$2.06 |
$2,313 |
D/D |
1,123 |
8,572,312 |
3.15 |
- |
|
FBIO |
Fortress Biotech, Inc. |
PRESIDENT, CEO & CHAIRMAN |
|
2020-12-01 |
4 |
A |
$2.34 |
$2,925 |
D/D |
1,250 |
9,376,700 |
0 |
- |
|
FBIO |
Fortress Biotech, Inc. |
PRESIDENT, CEO & CHAIRMAN |
|
2021-12-01 |
4 |
A |
$2.42 |
$3,025 |
D/D |
1,250 |
10,422,338 |
0 |
- |
|
FBIO |
Fortress Biotech, Inc. |
PRESIDENT, CEO & CHAIRMAN |
|
2021-06-01 |
4 |
A |
$2.31 |
$2,996 |
D/D |
1,297 |
10,408,336 |
0 |
- |
|
ATXI |
Avenue Therapeutics, Inc. |
Director |
|
2017-10-09 |
4 |
B |
$5.40 |
$7,290 |
D/D |
1,350 |
20,000 |
2.39 |
- |
|
FBIO |
Fortress Biotech, Inc. |
PRESIDENT, CEO & CHAIRMAN |
|
2019-06-03 |
4 |
B |
$1.10 |
$1,614 |
D/D |
1,467 |
8,571,189 |
3.15 |
- |
|
FBIO |
Fortress Biotech, Inc. |
PRESIDENT AND CEO |
|
2018-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,514 |
7,524,693 |
0 |
- |
|
164 Records found
|
|
Page 1 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|